RNPilotJournal of obstetric, gynecologic, and neonatal nursing : JOGNN2025

Feasibility and Acceptability of the We See You, Sis Sister Circle for Black Women With Depression Symptoms.

Kia Skrine Jeffers, Felica Jones, O Kenrik Duru

PMID 39627176

WHAT IT FOUND

Black women with depression symptoms found a six-week virtual sister circle feasible and acceptable.

They described it as a trusted space to be themselves and feel more whole. This was not a test of whether depression symptoms improved.

Key findings

01Of 43 women recruited, 30 enrolled and 25 remained active through the 12-week follow-up.

02Among 22 participants available during their group's meeting time, 18 attended four or more sessions.

03The focus group analysis identified two overarching themes: becoming more whole and having a trusted space to address depression symptoms and related experiences.

STILL TO COME

How it was doneWhat they foundWhat it means for RNs

Read the rest of this summary

You get three full summaries a month, free, and we do not ask for a card. Search, the TL;DRs and your library stay unlimited either way.

Already have one?

What it does not show

This was a small pilot with 30 enrolled women, so it cannot show that the sister circle reduces depression symptoms. Five participants were lost to follow-up and did not attend any session after enrollment. Acceptability was based on focus groups with 15 of 30 participants, so the views of absent participants are unknown. The study measured feasibility and acceptability, not depression outcomes. The 12-week timeframe limited information about long-term effects or long-term acceptability. The study did not measure participant satisfaction or intervention fidelity.

Declared interests

The article metadata lists NIH extramural research support; the author reported no conflicts of interest or relevant financial relationships.

The easy way to misread this

Do not read the completion rates and positive themes as evidence that depression symptoms improved. The study measured feasibility and acceptability, not symptom improvement.

Read it on PubMed →